
zzso drug monitoring is not routinely used for zzso zzso There are several reasons, but one major drawback is the lack of established therapeutic concentration zzso Combination chemotherapy makes the establishment of therapeutic ranges for individual drugs difficult, the zzso relationship for a single drug may not be the same as that when the drug is used in a drug zzso zzso zzso protocols for many classes of zzso compounds exist in specialized zzso and some of these protocols are now part of large zzso zzso Nonetheless, zzso is the only agent which is routinely monitored in most treatment zzso An additional factor, especially in zzso therapy, is the existence of zzso zzso which play a major role in drug zzso Monitoring of therapy could include zzso of zzso zzso activities or zzso in addition to, or instead of, the more traditional measurement of parent drug or drug zzso The zzso activities of zzso and zzso are regulated by zzso zzso zzso and zzso zzso zzso zzso Lack of zzso functional activity produces life-threatening zzso zzso Very low zzso activity reduces zzso breakdown producing severe zzso These zzso zzso can influence the zzso zzso toxicity and efficacy of their zzso zzso 

